Other urogenital candidiasis
ICD-10 B37.49 is a billable code used to indicate a diagnosis of other urogenital candidiasis.
Other urogenital candidiasis refers to fungal infections caused by Candida species that affect the urogenital tract, excluding the more common forms such as vulvovaginal candidiasis. This condition can manifest in various ways, including urethritis, cystitis, and other infections of the urinary tract and genital area. Patients may present with symptoms such as itching, burning, and abnormal discharge. The condition is particularly prevalent in immunocompromised individuals, such as those with HIV/AIDS, diabetes, or those undergoing immunosuppressive therapy. Diagnosis typically involves clinical evaluation and laboratory tests, including culture and sensitivity testing to identify the specific Candida species involved. Treatment usually involves antifungal medications, such as fluconazole or topical agents, and may require adjustments based on the patient's immune status and the severity of the infection. Understanding the nuances of this condition is crucial for accurate coding and effective treatment planning.
Detailed clinical notes on symptoms, laboratory results, and treatment plans.
Patients with recurrent urogenital infections, particularly those with underlying immunocompromising conditions.
Consideration of potential drug interactions with antifungal treatments and the patient's overall health status.
Comprehensive documentation of urinary symptoms, diagnostic tests, and treatment responses.
Patients presenting with urinary tract symptoms and a history of candidiasis.
Need to differentiate between candidiasis and other urogenital infections, such as bacterial cystitis.
Used when laboratory testing is performed to confirm the presence of Candida species.
Documentation of the clinical indication for testing and results.
Infectious disease specialists should ensure comprehensive documentation of the patient's history and symptoms.
Common symptoms include itching, burning during urination, abnormal discharge, and irritation in the genital area.
Diagnosis is typically made through clinical evaluation and laboratory tests, including cultures to identify the specific Candida species.
Common antifungal treatments include fluconazole, clotrimazole, and miconazole, depending on the severity and location of the infection.
Immunocompromised patients are at higher risk for severe infections, and their treatment may differ significantly from immunocompetent individuals.
